Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

from Answers from the Lab · host Mayo Clinic Laboratories

(00:32) Could you provide us some background about yourself?(01:34) Could you give us a brief overview of the new Mayo complete lung cancer assay?(03:31) Can you talk a little bit more about the specific genes and why they're important for patient care?(04:53) When would a clinician pathologist order a focused NGS panel, such as this new Mayo complete lung cancer panel, over a larger cancer panel? (07:27) What specimens are accepted for the Mayo complete lung cancer panel?(08:50) How are these molecular results used in patient care?

Episode metadata supplied by the publisher feed · Published Oct 25, 2022

Embed this episode

Attribution link and audio player

What this episode covers

Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making. The focused panel includes key DNA and RNA components and can provide rapid results from a range of patient specimens.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

0:00 11:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Answers from the Lab?

This episode is 11 minutes long.

When was this Answers from the Lab episode published?

This episode was published on October 25, 2022.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!